Body Myositis Study

Neurology Now
September/October 2007
Volume 3(5)
p 11
Back to top

THE EDITOR RESPONDS: Thank you for your letter, Jennifer. We hope this announcement helps your recruiting efforts.


To enroll in the Rituximab in Myositis (RIM) study, please contact the coordinating center at 412-647-3241 or visit the RIM study Web site at .

Back to top